Slowly progressive systemic mastocytosis with high mast-cell burden and no evidence of a non-mast-cell hematologic disorder: an example of a smoldering case?
- 1 July 2001
- journal article
- case report
- Published by Elsevier in Leukemia Research
- Vol. 25 (7) , 635-638
- https://doi.org/10.1016/s0145-2126(01)00023-6
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Diagnostic criteria and classification of mastocytosis: a consensus proposalLeukemia Research, 2001
- Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathologyBlood, 2000
- Clinical correlates of the presence of the asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosisCancer, 1998
- The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis.Journal of Clinical Investigation, 1995
- Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.Proceedings of the National Academy of Sciences, 1995
- Hematologic manifestations of systemic mast cell disease: A prospective study of laboratory and morphologic features and their relation to prognosisThe American Journal of Medicine, 1991